Gainers
- Geovax Labs GOVX shares increased by 30.93% to $5.63 during Thursday's after-market session. Trading volume for this security closed at 4.0 million, accounting for 913.51% of its average full-day volume over the last 100 days. The company's market cap stands at $35.6 million.
- Marker Therapeutics MRKR stock moved upwards by 25.59% to $2.11. Marker Therapeutics's trading volume hit 737.6K shares by close, accounting for 73.28% of its average volume over the last 100 days. The company's market cap stands at $175.2 million.
- Sorrento Therapeutics SRNE shares moved upwards by 6.78% to $8.81. Trading volume for this security closed at 442.6K, accounting for 6.78% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.6 billion.
- Aditxt ADTX shares increased by 5.85% to $1.99. The company's market cap stands at $29.2 million.
- Genocea Biosciences GNCA shares rose 5.74% to $1.84. The company's market cap stands at $104.9 million.
- InVivo Therapeutics Hldg NVIV shares rose 5.1% to $0.7. At the close, InVivo Therapeutics Hldg's trading volume reached 442.5K shares. This is 53.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $23.9 million. The company's, Q2 earnings came out 4 days ago.
Losers
- Progenity PROG stock fell 22.82% to $1.15 during Thursday's after-market session. Trading volume for this security closed at 541.2K, accounting for 22.42% of its average full-day volume over the last 100 days. The company's market cap stands at $91.3 million.
- Fate Therapeutics FATE shares fell 9.67% to $77.35. The company's market cap stands at $7.3 billion.
- Sonnet BioTherapeutics SONN shares declined by 8.2% to $1.12. At the close, Sonnet BioTherapeutics's trading volume reached 1.0 million shares. This is 107.66% of its average volume over the last 100 days. The market value of their outstanding shares is at $23.9 million. The company's, Q3 earnings came out 3 days ago.
- Sonoma Pharmaceuticals SNOA shares decreased by 7.61% to $7.53. Trading volume for this security closed at 958.8K, accounting for 902.12% of its average full-day volume over the last 100 days. The company's market cap stands at $15.7 million. As per the press release, Q1 earnings came out 3 days ago.
- AzurRx BioPharma AZRX shares declined by 5.71% to $0.6. The company's market cap stands at $55.9 million. As per the press release, Q2 earnings came out 3 days ago.
- Salarius Pharmaceuticals SLRX shares declined by 3.9% to $0.87. The market value of their outstanding shares is at $38.9 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in